Efficacy and safety of saroglitazar 4 mg compared to fenofibrate 160 mg in latino adults with moderate to severe hypertriglyceridemia-a randomized clinical trial. (August 2022)

Record Type:: Journal Article
Title:: Efficacy and safety of saroglitazar 4 mg compared to fenofibrate 160 mg in latino adults with moderate to severe hypertriglyceridemia-a randomized clinical trial. (August 2022)
Main Title:: Efficacy and safety of saroglitazar 4 mg compared to fenofibrate 160 mg in latino adults with moderate to severe hypertriglyceridemia-a randomized clinical trial
Authors:: Parmar, D.
Rodriguez-Gutierrez, R.
González-González, J.G.
Shaikh, F.
Cruz-López, J.L.P.
Abstract:
Is Part Of:: Atherosclerosis. Volume 355(2022)
Journal:: Atherosclerosis
Issue:: Volume 355(2022)
Issue Display:: Volume 355, Issue 2022 (2022)
Year:: 2022
Volume:: 355
Issue:: 2022
Issue Sort Value:: 2022-0355-2022-0000
Page Start:: 257
Page End:
Publication Date:: 2022-08
Subjects:: Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:: http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.atherosclerosis.2022.06.975 ↗
Languages:: English
ISSNs:: 0021-9150
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23286.xml